These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8294670)

  • 21. [On an attempt for juvenile periodontitis therapy. Part 1. The effect of systemic administration of antibiotics for juvenile periodontitis].
    Ueda M; Teranishi Y; Fujiwara K; Hashizume A; Yamaoka A; Yamanaka T; Takeuchi H; Minonishi A; Fujiwara S; Fujii T
    Nihon Shishubyo Gakkai Kaishi; 1988 Sep; 30(3):915-25. PubMed ID: 3253357
    [No Abstract]   [Full Text] [Related]  

  • 22. [Critical assessment of microbiological diagnostics in periodontal diseases with special focus on Porphyromonas gingivalis].
    Walter C; Purucker P; Bernimoulin JP; Suttorp N; Meyer J; Weiger R
    Schweiz Monatsschr Zahnmed; 2005; 115(5):415-24. PubMed ID: 15960451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease.
    Kugaji MS; Kumbar VM; Peram MR; Patil S; Bhat KG; Diwan PV
    APMIS; 2019 Apr; 127(4):187-195. PubMed ID: 30861212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Green tea catechins potentiate the effect of antibiotics and modulate adherence and gene expression in Porphyromonas gingivalis.
    Fournier-Larente J; Morin MP; Grenier D
    Arch Oral Biol; 2016 May; 65():35-43. PubMed ID: 26849416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimicrobial approaches to periodontal therapy].
    Vitaya CT
    J Dent Assoc Thai; 1990; 40(2):83-91. PubMed ID: 2074322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medications: a risk factor for periodontal disease diagnosis and treatment.
    Ciancio SG
    J Periodontol; 2005 Nov; 76(11 Suppl):2061-5. PubMed ID: 16277577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Action of Myricetin on Porphyromonas gingivalis and the Inflammatory Response of Host Cells: A Promising Therapeutic Molecule for Periodontal Diseases.
    Grenier D; Chen H; Ben Lagha A; Fournier-Larente J; Morin MP
    PLoS One; 2015; 10(6):e0131758. PubMed ID: 26121135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation and identification of Capnocytophaga in localized juvenile periodontitis. Preliminary study].
    Chung HJ; Son S; Chung CP
    Taehan Chikkwa Uisa Hyophoe Chi; 1986 Jan; 24(1):73-9. PubMed ID: 3519809
    [No Abstract]   [Full Text] [Related]  

  • 30. Virulence of major periodontal pathogens and lack of humoral immune protection in a rat model of periodontal disease.
    Verma RK; Bhattacharyya I; Sevilla A; Lieberman I; Pola S; Nair M; Wallet SM; Aukhil I; Kesavalu L
    Oral Dis; 2010 Oct; 16(7):686-95. PubMed ID: 20846155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycoplasma in periodontal disease. Isolation in juvenile periodontitis.
    Newman MG; Saglie R; Carranza FA; Kaufman AK
    J Periodontol; 1984 Oct; 55(10):574-80. PubMed ID: 6387080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on Actinobacillus Actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease.
    Slots J
    J Int Acad Periodontol; 1999 Oct; 1(4):121-6. PubMed ID: 12666957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status.
    Wang H; Ai L; Zhang Y; Cheng J; Yu H; Li C; Zhang D; Pan Y; Lin L
    Biomed Res Int; 2018; 2018():1805793. PubMed ID: 29736391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance after a complex orthoperio treatment in a case of generalized aggressive periodontitis: 7-year result.
    Zafiropoulos GG; di Prisco MO; Deli G; Hoffmann O; Kasaj A
    J Int Acad Periodontol; 2010 Oct; 12(4):112-22. PubMed ID: 21128529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of IgG antibody reactive with Bacteroides forsythus and Porphyromonas gingivalis in adult and early-onset periodontitis.
    Califano JV; Gunsolley JC; Schenkein HA; Tew JG
    J Periodontol; 1997 Aug; 68(8):734-8. PubMed ID: 9287063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing for periodontal disease.
    Blair FM; Chapple IL
    Prim Dent J; 2014 Nov; 3(4):38-43. PubMed ID: 25668374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periodontal microbiology: the current controversy.
    Baer PN
    N Y State Dent J; 1986 May; 52(5):22-3. PubMed ID: 3458098
    [No Abstract]   [Full Text] [Related]  

  • 38. Periodontal pathogens and associated factors in aggressive periodontitis: results 5-17 years after active periodontal therapy.
    Meyer-Bäumer A; Eick S; Mertens C; Uhlmann L; Hagenfeld D; Eickholz P; Kim TS; Cosgarea R
    J Clin Periodontol; 2014 Jul; 41(7):662-72. PubMed ID: 24708362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of periodontal infections.
    Trieger N
    Atlas Oral Maxillofac Surg Clin North Am; 2000 Mar; 8(1):27-34. PubMed ID: 11212385
    [No Abstract]   [Full Text] [Related]  

  • 40. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis.
    Holt SC; Ebersole JL
    Periodontol 2000; 2005; 38():72-122. PubMed ID: 15853938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.